Dr Teh completed his PhD in 2000 at King’s College London followed by postdoctoral studies at Queen Mary University of London (QMUL). He is now a Senior Lecturer at the Centre of Oral Immunobiology and Regenerative Medicine, Barts and the London School of Medicine and Dentistry, QMUL. Dr Teh was awarded “Molecule of the Year 2010” for his pioneering research on FOXM1 in human cancer initiation. He has published over 50 papers in high impact journals and also as editorial board member of several reputed journals. His leads a clinical translational research group investigating disease biomarkers and mechanisms of molecular reprogramming.
Biomarkers and mechanisms of Molecular Reprograming.